These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. Albert MA; Danielson E; Rifai N; Ridker PM; JAMA; 2001 Jul; 286(1):64-70. PubMed ID: 11434828 [TBL] [Abstract][Full Text] [Related]
30. Statins for prevention of stroke. Rosendorff C Lancet; 1998 Apr; 351(9108):1002-3. PubMed ID: 9546501 [No Abstract] [Full Text] [Related]
31. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial. Hunt D; Young P; Simes J; Hague W; Mann S; Owensby D; Lane G; Tonkin A Ann Intern Med; 2001 May; 134(10):931-40. PubMed ID: 11352694 [TBL] [Abstract][Full Text] [Related]
33. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial. Pearson TA; Denke MA; McBride PE; Battisti WP; Brady WE; Palmisano J Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425 [TBL] [Abstract][Full Text] [Related]
34. Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis. Afilalo J; Duque G; Steele R; Jukema JW; de Craen AJ; Eisenberg MJ J Am Coll Cardiol; 2008 Jan; 51(1):37-45. PubMed ID: 18174034 [TBL] [Abstract][Full Text] [Related]
35. Where to draw the line using statins: lessons from 4S to AFCAPS/TexCAPS. Sprecher DL Cleve Clin J Med; 2000 Mar; 67(3):169-71. PubMed ID: 10743305 [No Abstract] [Full Text] [Related]
36. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818 [TBL] [Abstract][Full Text] [Related]
37. Statin lipid-lowering therapy for acute myocardial infarction and unstable angina: efficacy and mechanism of benefit. Wright RS; Murphy JG; Bybee KA; Kopecky SL; LaBlanche JM Mayo Clin Proc; 2002 Oct; 77(10):1085-92. PubMed ID: 12374252 [TBL] [Abstract][Full Text] [Related]
39. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA; 2002 Dec; 288(23):2998-3007. PubMed ID: 12479764 [TBL] [Abstract][Full Text] [Related]
40. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Evans M; Roberts A; Davies S; Rees A Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]